联环药业：口服溶液1号生产线新建后首次通过药品GMP符合性检查

Core Insights - Lianhuan Pharmaceutical (600513.SH) announced that its wholly-owned subsidiary, Lianhuan (Anqing), has received the "Drug GMP Compliance Inspection Notification" from the Anhui Provincial Drug Administration [2] - This inspection is based on the contract manufacturing of Ebastine oral solution (National Drug Approval Number H20243410) and marks the first successful GMP compliance inspection for the newly established oral solution production line [2] - The investment in the oral solution production line amounts to approximately 7.5 million yuan [2]